ΑΡΑΠΟΓΙΑΝΝΗ ΑΘΗΝΑ Αναπληρώτρια Διευθύντρια Γ Καρδιολογικής Κλινικής Ευρωκλινικής Αθηνών

Similar documents
Smoking cessation and weight gain

Fructose in Insulin Resistance- Focused on Diabetes 순천향대학교부천병원 내분비내과 정찬희

Tabac et Lipides. Michel FARNIER, MD, PhD, Dijon

Nutrition and gastrointestinal cancer: An update of the epidemiological evidence

Chapter (5) Etiology of Low HDL- Cholesterol

OBESITY IN PRIMARY CARE

1Why lipids cannot be transported in blood alone? 2How we transport Fatty acids and steroid hormones?

NOT-FED Study New Obesity Treatment- Fasting, Exercise, Diet

Management of Tobacco Dependence. Dr. Lokesh Kumar Singh Associate Professor Department of Psychiatry AIIMS, Raipur

Role of apolipoprotein B-containing lipoproteins in the development of atherosclerosis Jan Borén MD, PhD

NICOTINE PHARMACOLOGY and PRINCIPLES of ADDICTION. 3 rd of 3 Prep for Session 1

PHARMACOTHERAPY OF SMOKING CESSATION

Non alcoholic fatty liver disease and atherosclerosis Raul Santos, MD

Obesity D R. A I S H A H A L I E K H Z A I M Y

Supplemental Table S2: Subgroup analysis for IL-6 with BMI in 3 groups

Physical activity as an aid for smoking cessation

Diabesity. Metabolic dysfunction that ranges from mild blood glucose imbalance to full fledged Type 2 DM Signs

Tobacco & Nicotine: Addiction and Treatment

THE IMPORTANCE OF EXERCISE FOR THE OVERWEIGHT AND OBESE PATIENT. Anneliese Piazza, MS, CPT

Fructose in diabetes: Friend or Foe. Kim Chong Hwa MD,PhD Sejong general hospital, Division of Endocrinology & Metabolism

Of Cows and Men: Reviewing the Link Between Dairy Fat and Human Health

Trends in electronic cigarette use in England

Pathophysiology of Lipid Disorders

Discussion points. The cardiometabolic connection. Cardiometabolic Risk Management in the Primary Care Setting

Andrew Cohen, MD and Neil S. Skolnik, MD INTRODUCTION

Tobacco Dependence Treatment From Neurobiology through Public Policy

13/09/2012. Dietary fatty acids. Triglyceride. Phospholipids:

Weight Loss Principles

Pattern of lipid biomarkers and risk of cardiovascular disease

Digestion: Endocrinology of Appetite

How to help your patient quit smoking. Christopher M. Johnson MD, PhD

UNDERSTANDING AND MANAGING METABOLIC SYNDROME IN PSYCHIATRY Dr Sanil Rege MBBS, MRCPsych, FRANZCP Consultation-Liaison Psychiatry PaRK MHS, Western

Cardiovascular Disease Risk Factors:

Diabetes Mellitus: A Cardiovascular Disease

Replacement Of Partially Hydrogenated Soybean Oil By Palm Oil In Margarine Without Unfavorable Effects On Serum Lipoproteins

Zuhier Awan, MD, PhD, FRCPC

DYSLIPIDEMIA RECOMMENDATIONS

FoodGate: The break-in, cover-up, and aftermath. Robert H. Lustig, M.D., M.S.L. Cristin Kearns, D.D.S., M.B.A. Laura Schmidt, Ph.D., M.P.H., L.C.S.W.

Figure S1. Comparison of fasting plasma lipoprotein levels between males (n=108) and females (n=130). Box plots represent the quartiles distribution


Energy balance. Factors affecting energy input. Energy input vs. Energy output Balance Negative: weight loss Positive: weight gain

NOTES. Developed by Fabio Comana, MA., MS., All rights Reserved Page 1

Supplementary Online Content

Project TEACH Addressing Tobacco Treatment for Pregnant Women Jan Blalock, Ph.D.

Metabolic Syndrome: An overview. Kevin Niswender MD, PhD Vanderbilt University School of Medicine

Metabolic defects underlying dyslipidemia in abdominal obesity

3/20/2011. Body Mass Index (kg/[m 2 ]) Age at Issue (*BMI > 30, or ~ 30 lbs overweight for 5 4 woman) Mokdad A.H.

Establishment of Efficacy of Intervention in those with Metabolic Syndrome. Dr Wendy Russell - ILSI Europe Expert Group

Project ECHO Importance of Treating Tobacco Use In People With Behavioral Health Disorders Jan Blalock, Ph.D.

THE CLINICAL BIOCHEMISTRY OF LIPID DISORDERS

Impact of Physical Activity on Metabolic Change in Type 2 Diabetes Mellitus Patients

Term-End Examination December, 2009 MCC-006 : CARDIOVASCULAR EPIDEMIOLOGY

Energy balance. Factors affecting energy input. Energy input vs. Energy output Balance Negative: weight loss Positive: weight gain

Genetics of Nicotine Dependence & Impact of Smoking on Bladder Cancer Risk and Prognosis

Metabolism, Atherogenic Properties and Agents to reduce Triglyceride-Rich Lipoproteins Manfredi Rizzo, MD, PhD

Widespread concern about the role of SFA in heart disease: Is it justified?

Relationship of insulin resistance with Lipid profile markers in cigarette smoker

SMOKING CESSATION WORKSHOP. Dr Mark Palayew December

There are many ways to lower triglycerides in humans: Which are the most relevant for pancreatitis and for CV risk?

WEIGHT LOSS/MANAGEMENT IS IT JUST ANOTHER PIPE DREAM?

Review of guidelines for management of dyslipidemia in diabetic patients

MOLINA HEALTHCARE OF CALIFORNIA

The art of tracing dietary fat in humans. Leanne Hodson

Smoking Cessation. Hassan Sajjad Pulmonary & Critical Care

The Hunger Games Reviewing the Evidence on Intermittent Fasting. Monique Piderit, RD

Subject Index. postprandial glycemia and suppression in serum 51 recommendations 119, 120 supplementation pros and cons 118, 119

Intermittent Fasting, Carb Cycling and Weight Management. Brent Agin, MD

Lipid Profiles. Important: Read over the section on correlation coefficients in the Guidelines for Statistics and Graphs in General Education Biology.

Bachelorarbeit Fructose and weight gain

Heather Dacus, DO, MPH Preventive Medicine Physician Director, Bureau of Chronic Disease Control New York State Department of Health

Smoking Cessation: Good News at Last!

Risk Factors for Heart Disease

Test5, Here is Your My5 to Health Profile with Metabolic Syndrome Insight

PIEDMONT ACCESS TO HEALTH SERVICES, INC. Guidelines for Screening and Management of Dyslipidemia

BASIC SKILLS FOR WORKING WITH SMOKERS

EvidenceNOW SW Learning Collaborative. Kyle Knierim, MD January 2017

Elevated Serum Levels of Adropin in Patients with Type 2 Diabetes Mellitus and its Association with

Misperceptions still exist that cardiovascular disease is not a real problem for women.

Management of Obesity. Objectives. Background Impact and scope of Obesity. Control of Energy Homeostasis Methods of treatment Medications.

Exercise Studies Where Walking is Better than Running: Does Intensity Matter?

Smoking and Smoking Cessation in England 2011: Findings from the Smoking Toolkit Study

Facts on Fats. Ronald P. Mensink

HIGH LDL CHOLESTEROL IS NOT AN INDEPENDENT RISK FACTOR FOR HEART ATTACKS AND STROKES

When Diet and Exercise Aren t Enough: Pharmacologic Management of Obesity

Disclosures. Nutrition & Menopause. What changes? Mindless Eating 10/6/2017. I have no disclosures

METABOLIC SYNDROME AND HCV: FROM HCV

Effective Treatments for Tobacco Dependence

Smoking Cessation A Clinicians Perspective. Jeff Wilson, MD

Metabolic and clinical aspects of sugar, fructose, soft drinks Dr. Shira Zelber-Sagi School of Public Health, Faculty of Social Welfare and Health

Obesity Management in Patients with Diabetes Jamy D. Ard, MD Sunday, February 11, :15 a.m. 11:00 a.m.

Pharmacological Treatments for Tobacco Users with Behavioral Health Conditions

DYSLIPIDEMIA PHARMACOLOGY. University of Hawai i Hilo Pre- Nursing Program NURS 203 General Pharmacology Danita Narciso Pharm D

Cardiovascular Complications of Diabetes

Metabolic Syndrome. Shon Meek MD, PhD Mayo Clinic Florida Endocrinology

Supporting smokers with mental health problems

Low-Carbohydrate Diets and All-Cause and Cause-Specific Mortality: A Population-based Cohort Study and Pooling Prospective Studies

What could a public health strategy for weight loss look like? Paul Aveyard Professor of behavioural medicine

OBESITY IN TYPE 2 DIABETES

Getting Ahead of the Curve in the Trouble with Fat

An Evolving Perspective on Smoking Cessation Therapies

Transcription:

ΑΡΑΠΟΓΙΑΝΝΗ ΑΘΗΝΑ Αναπληρώτρια Διευθύντρια Γ Καρδιολογικής Κλινικής Ευρωκλινικής Αθηνών

Δεν υπάρχει σύγκρουση συμφερόντων

Mets and Cigarette Smoking Status Nicotine- one of the most heavily used addictive drugs (NIDA,2009) >1 billion people are smokers ( 1/3 of adult world population) Many studies reported a higher incident of MetS in smokers

13 prospective cohort studies, 56,691 pts Relative risks of metabolic syndrome for active smokers compared with nonsmokers. Active Smokers : 26% risk of MetS Sun K, Liu J, Ning G (2012) Active Smoking and Risk of Metabolic Syndrome: A Meta-Analysis of Prospective Studies. PLOS ONE 7(10): e47791. https://doi.org/10.1371/journal.pone.0047791 http://journals.plos.org/plosone/article?id=10.1371/journal.pone.0047791

Life Lines Cohort Study, N=59,467 BMC Med. 2013;11:2735.

Influence of cigarette smoking on MetS

Release of nicotine Arginine vasopresssin Corticotropin-releasing hormone Adrenocorticotropic hormone Growth hormone Dopamine Serotonin γ-aminobutiric acid Acetylcholine Epinephrine, norepinephrine Cortisol J Audrain-McGovern and NL Benowitz, Clin Pharmacol Ther. 2011 Jul; 90(1): 164 168

Release of nicotine Nicotine and Insulin Resistance: When the Smoke Clears Diabetes 2012 Dec; 61(12): 3078-3080

Provoke inflammatory reaction Mean values for CRP in sex, diabetes, and obesity subgroups, stratified by smoking status. Russell P. Tracy et al. Arterioscler Thromb Vasc Biol. 1997;17:2167-2176

Influence on leptin, adiponectin and ghrelin levels Despite the well-known inverse association between smoking and body weight, there have been conflicting reports on the effects of smoking on serum leptin and adiponectin levels. Kolovou G, et al. Clininical Lipidology,2016,11:1,6-14

Impaired plasma lipid profile TC, TG, LDL-C HDL Smoking oxidative stress HDL undergo changes in structure or composition, losing normal biological behaviours. Smoking cortisol levels abdominal fat Low lipoprotein lipase activity free FAs, hepatic synthesis of VLDL TG Abdominal obesity, IR sdldl If fatty liver present ( MetS)- de novo synthesis of TGs, affect LDL particle size Kolovou G, et al. Clininical Lipidology,2016,11:1,6-14

Obesity and Smoking Smokers are more likely to have lower BMI Am J Public Health 1987;77:439-444

Mechanisms by which cigarette smoking reduces body weight Harris K, et al. Nat Rev Endocrinol. 2016 May; 12(5): 299 308

Obes Res. 2002;10:891 895.

Insulin Resistance Mechanisms by which nicotine leads to insulin resistance Harris K, et al. Nat Rev Endocrinol. 2016 May; 12(5): 299 308

Atheroscler Thromb. 1994;14:1946-1950

Smoking cessation and MetS 35 studies, 63,403 ex-smokers and 388,432 smokers Individuals who stopped smoking had a significant association with absolute weight gain; among these individuals the mean weight gain was 4.10 kg (95% CI 2.69 5.51; P <0.001 compared to those who continued to smoke) whereas the mean increase in BMI was 1.14 kg/m 2 units over a 5-year period. (95% CI 0.50 1.79; P= 0.137 compared to those who continued to smoke). Obes. Rev. 2015;16:883 901.

Changes in BMI over 10 years with smoking status The mean increase in caloric intake was 227 calories per day in those who quit smoking, which explains up to 69% of the weight gained at 3 months postcessation Harris K, et al. Nat Rev Endocrinol. 2016 May; 12(5): 299 308

Of those who stop smoking, 13% gained >10 kg in a year, with weight gain greatest in the first few months after cessation and continuing to increase for 6 months N Engl J Med. 1991 Mar 14;324(11):739-45.

In all groups, weight increased by about 1 kg per month for the first three months. BMJ. 2012; 345: e4439

treated with nicotine replacement therapy treated with bupropion treated with varenicline The pattern or amount of weight gain was not reduced by pharmacotherapy. Similar weight gains occurred in individuals not receiving pharmacotherapy and in those using nicotine replacement, bupropion or varenicline.

those with a lower BMI gained more weight than those with a higher BMI Addiction. 2011 Jan;106(1):188-96

Younger participants gained more weight than older participants. For light smokers, men gained more weight than women, whereas for heavy smokers, women gained more weight than men. These findings suggest that young women who smoke heavily are at the highest risk of gaining weight after quitting smoking. Int J Environ Res Public Health. 2014 Aug; 11(8): 8443 8455.

High nicotine dependence was also associated with the greatest weight gain after cessation Prod hom S, et al. Nicotine Tob. Res. 2013;15:910 916

N=9,018 J Atheroscler Thromb. 2018 Jan 1; 25(1): 90 9

Smoking Cessation BMI and fat mass Marked fasting hyperinsulinaemia, fast insulin resistance

Mechanism-theories The ability of nicotine to suppress appetite is reversed Nicotine absence the rewarding value of food snacs high in carbohydrates and sugars Socioeconomic status. The majority of smokerslower SES- physical activity, high-calorie, highfat diets Marked changes of intestinal microbiota Nat Rev Endocrinol.2016;12(5):299-308

Personalized weight- management programs

Conclusions Smoking cessation can lead to weight gain. Post-cessation-related obesity might contribute to insulin resistance (improvement in insulin sensitivity over time) The number one reason for not wanting to quit smoking or quitting and then relapsing is fear of post-cessation weight gain, especially in women and in individuals with obesity Future smoking cessation programs and therapies need to be designed with an emphasis on reducing post-cessation weight gain The benefits of smoking cessation outweigh the risks

Μια καλή ομιλία πρέπει να εξαντλεί το θέμα, όχι όμως και το ακροατήριο. Winston Churchill